View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, Nov. 30 (HealthDay News) -- Misdiagnosis of intrauterine pregnancies as ectopic, with subsequent first-trimester exposure to high-dose methotrexate, may result in severely malformed newborns or fetal deaths, according to a study published in the December issue of the American Journal of Obstetrics & Gynecology.
Laila Nurmohamed, M.D., from the University of Toronto, and colleagues reported the outcomes of eight intrauterine pregnancies that were misdiagnosed as ectopic. All subjects were exposed to high-dose methotrexate in the first trimester to induce abortion in the presumed ectopic pregnancies, which were later identified as viable intrauterine pregnancies.
The investigators found that all of the pregnancies resulted in catastrophic outcomes. In two of the pregnancies, newborns were severely malformed, with methotrexate embryopathy. Three women were advised to undergo surgical termination, and three women miscarried shortly after exposure to methotrexate.
"The misdiagnosis of desired, intrauterine pregnancies as ectopic with subsequent exposure to high-dose methotrexate during embryogenesis may result in the birth of severely malformed babies, miscarriage, or induced abortion," the authors write. "Effective, nonpunitive reporting mechanisms should be sought, to determine the true magnitude of this phenomenon and to facilitate improvement in point-of care diagnostic accuracy of early ectopic pregnancies."
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top